<\/p>\n\n\n\n
You’ve heard the statistics and you may have lived them: about one in five pregnancies ends in miscarriage. If you’ve experienced more than one miscarriage, you’ve probably also heard the phrase that cuts deepest of all: \u201cSometimes it just happens\u2014at least you know you can get pregnant, now.\u201d<\/em> Maybe a kind doctor patted your hand and said your body would figure it out. Maybe you were told to try again. Maybe you were told that one miscarriage is random and to come back if you have more. Maybe no one ran a single additional test.<\/p>\n\n\n\n But what if the answer wasn’t just \u201cbad luck?\u201d What if your immune system\u2014that same relentless, microscopic army designed to protect you\u2014was quietly and catastrophically doing its job too well<\/em>?<\/p>\n\n\n\n This is the question at the heart of reproductive immunology, a field that is reshaping how we understand pregnancy loss, recurrent miscarriage, and unexplained infertility. It is not fringe or even alternative science. It is not a last resort for the desperate. It is increasingly one of the most important frontiers in women’s medicine. And it starts with understanding something remarkable about pregnancy itself.<\/p>\n\n\n\n Every pregnancy is, at its biological core, a paradox. Your baby carries DNA that is only half yours. The other half comes from the father and is genetically foreign to your body. Under normal immunological logic, your immune system should attack that foreign tissue the same way it would attack a transplanted organ or an invading pathogen. It should reject it.<\/p>\n\n\n\n And yet, in the majority of healthy pregnancies, it doesn’t.<\/p>\n\n\n\n The fact that human pregnancy works at all is (from an immunologist’s perspective) something close to a miracle. A successful pregnancy requires the maternal immune system to perform a breathtaking act of selective tolerance. Meaning, it stands down against the semi-foreign embryo while remaining alert enough to defend against genuine threats like bacteria and viruses. This isn’t passive. It’s an active, highly orchestrated immunological process, and when it goes wrong, pregnancy can fail.<\/p>\n\n\n\n The fact that human pregnancy works at all is (from an immunologist’s perspective) something close to a miracle. A successful pregnancy requires the maternal immune system to perform a breathtaking act of selective tolerance. Meaning, it stands down against the semi-foreign embryo while remaining alert enough to defend against genuine threats like bacteria and viruses.<\/p><\/blockquote><\/figure>\n\n\n\n Understanding how<\/em> it goes wrong is the entire mission of reproductive immunology.<\/p>\n\n\n\n The story of reproductive immunology as a clinical discipline begins, in large part, with one relentlessly curious physician: Dr. Alan Beer, an immunologist and obstetrician who spent decades asking questions that mainstream medicine was not yet ready to hear.<\/p>\n\n\n\n Working from the late 1970s onward\u2014initially at the University of Michigan and later at the University of Texas\u2014Beer<\/a> began studying women who were perfectly healthy by every conventional measure, yet couldn’t sustain a pregnancy [1]. These were women who conceived without difficulty but miscarried repeatedly, often after being told their losses were chromosomal flukes or unexplained. Beer and his patients were unconvinced.<\/p>\n\n\n\n What Dr. Beer found, through painstaking laboratory work, was that many of these women had immune system abnormalities that were interfering with implantation and early placental development. Autoantibodies<\/a>\u2014proteins made by the immune system that mistakenly target the body’s own tissues\u2014were damaging the delicate blood vessels of the early placenta [2]. Natural killer cells, a type of immune cell critical to the body’s defenses, were behaving aberrantly, attacking the embryo rather than protecting it. The body, in short, was treating the pregnancy as a threat to be neutralized. As a virus of sorts threatening the mother\u2019s body. <\/p>\n\n\n\n What Dr. Beer found, through painstaking laboratory work, was that many of these women had immune system abnormalities that were interfering with implantation and early placental development. Autoantibodies\u2014proteins made by the immune system that mistakenly target the body’s own tissues\u2014were damaging the delicate blood vessels of the early placenta.<\/p><\/blockquote><\/figure>\n\n\n\n Beer’s work was groundbreaking and, at the time, deeply controversial. Colleagues pushed back. The field was not yet ready to accept that the immune system could be a root cause of pregnancy loss. But he kept going. He kept publishing prolifically, treating patients, and building a body of evidence that would outshine the skeptics.<\/p>\n\n\n\n By the time he passed away in 2006, Beer had seen reproductive immunology transform from a fringe hypothesis into a legitimate medical subspecialty. His book Is Your Body Baby Friendly<\/em><\/a>?<\/em>, first published in 2006 and updated in 2019, remains essential reading for anyone navigating recurrent pregnancy loss. He is, without overstatement, widely considered the father of reproductive immunology.<\/p>\n\n\n\n So what, exactly, goes wrong immunologically when a pregnancy fails? The science is complex, but the core story involves several key players.<\/p>\n\n\n\n These are among the most important immune cells at the maternal-fetal interface. Uterine natural killer (uNK) cells are not the same as their blood-circulating counterparts. These cells are specialized, less cytotoxic, and under normal circumstances, they play a helpful<\/em> role in early pregnancy. They support trophoblast invasion (the process by which the embryo anchors into the uterine wall) and remodel<\/a> the spiral arteries to deliver nutrients and oxygen to the growing placenta [3].<\/p>\n\n\n\n But when uNK cells are elevated or dysfunctional, they can shift from protectors to destroyers. A 2022 systematic review and meta-analysis<\/a> published in Human Reproduction Update<\/em> confirmed that elevated uNK cell counts are associated with recurrent miscarriage and recurrent implantation failure, and that inappropriate uNK function has been implicated in reproductive failure [4]. More recent research published in Fertility and Sterility<\/em> in 2023 further underscored that uNK cells are “critical in early gestation and implantation” and that their dysregulation may be a significant but underdiagnosed cause of pregnancy loss [3].<\/p>\n\n\n\n If NK cells are the soldiers, regulatory T cells are the peacekeepers. Tregs are a specialized subset of immune cells whose job, in pregnancy, is to suppress the immune response against paternal antigens. Essentially, they are training the body to tolerate the “foreign” embryo. Research<\/a> published in the Journal of Clinical Investigation<\/em> describes Tregs as “master regulators of pregnancy tolerance,” noting that they operate to inhibit effector immunity, contain inflammation, and support the vascular adaptations needed for the placenta to function [5].<\/p>\n\n\n\n When Treg numbers are low or functionally deficient, this tolerance breaks down. A comprehensive review<\/a> in Human Reproduction Update<\/em> found that inadequate Treg cells are linked with infertility, miscarriage, and pre-eclampsia [6]. Animal studies<\/a> have gone even further: murine (i.e., mouse) miscarriage can actually be prevented<\/em> by transferring regulatory T cells from normally pregnant mice. This finding has profound implications for future human therapies [7].<\/p>\n\n\n\n This is the most well-established immunological cause of recurrent pregnancy loss, and the one where mainstream medicine has made the clearest therapeutic progress. Antiphospholipid syndrome is an autoimmune condition in which the body produces antibodies that attack phospholipids (the fatty molecules found in cell membranes). In pregnancy, these antibodies can cause<\/a> clotting in the placental blood vessels, starving the embryo of the oxygen and nutrients it needs to survive [8].<\/p>\n\n\n\n APS is now recognized as the most important treatable<\/em> autoimmune cause of recurrent miscarriage, and the combination of low-dose aspirin and heparin (which are two anticoagulant treatments), has a success rate of approximately 70\u201380% in high-risk patients [8]. This is a remarkable outcome for women who, without testing and diagnosis, might have been sent home and told simply to try again. It\u2019s also a triumph and joy, to know that this available treatment is so simple and accessible.\u00a0<\/p>\n\n\n\n APS is now recognized as the most important treatable<\/em> autoimmune cause of recurrent miscarriage, and the combination of low-dose aspirin and heparin (which are two anticoagulant treatments), has a success rate of approximately 70\u201380% in high-risk patients. This is a remarkable outcome for women who, without testing and diagnosis, might have been sent home and told simply to try again.<\/p><\/blockquote><\/figure>\n\n\n\n Here is the part that matters most for women sitting in the middle of this grief: the mainstream medical approach to recurrent miscarriage still leaves up to 50% of cases “unexplained.”<\/p>\n\n\n\n A 2025 paper<\/a> published in the International Journal of Molecular Sciences<\/em> confirmed that recurrent pregnancy loss affects 3\u20135% of women trying to conceive, and that despite extensive investigation, the causes in a significant proportion of cases “remain unexplained” [9]. Another 2020 review put the figure even higher, noting that more than half of RPL cases still lack a clear diagnosis [10]. It\u2019s important to keep in mind that miscarriage statistics must be taken with some nuance given that many women miscarry without knowing or reporting, so accurate data is almost impossible. Nonetheless, the numbers above are based on reported miscarriages. <\/p>\n\n\n\n Reproductive immunology offers a framework for investigating some of those unexplained cases. But it requires specialized testing that is not part of standard recurrent miscarriage workups in most countries.<\/p>\n\n\n\n Women with recurrent pregnancy loss; which is typically defined as two or more consecutive losses, per the current ESHRE (European Society of Human Reproduction and Embryology) 2022 guidelines, may benefit from evaluation that includes antiphospholipid antibody screening, NK cell panels (both peripheral blood and uterine biopsy), cytokine profiling, and assessment of HLA compatibility between partners. Thyroid antibodies, which have been independently associated with pregnancy loss risk, should also be evaluated. Consult the medical professionals available to you in order to determine which testing might be most appropriate. <\/p>\n\n\n\n It is worth noting that this field is not without controversy. While practitioners of restorative reproductive medicine (RRM)<\/a> take a more thorough approach<\/a> to repeated miscarriage, mainstream reproductive medicine bodies, including the American Society of Reproductive Medicine (ASRM), currently only formally validate heparin and aspirin for antiphospholipid syndrome-related pregnancy loss, and do not yet recommend broader immunomodulatory treatments as standard care [11]. This does not mean the science is wrong, it means the clinical trials needed to satisfy guideline bodies are still catching up to the immunological findings. Well-powered randomized controlled trials are urgently needed, and researchers in the field are calling for exactly that [3].<\/p>\n\n\n\n For women who test positive for immunological abnormalities, treatments currently being studied and used in specialized clinics include:<\/p>\n\n\n\n Reproductive immunology is young, contested, and like all newer sciences, it is imperfect. Not every clinic offering immune testing is doing so with the same rigor. Not every test result tells a complete story. And the translation from lab finding to clinical treatment remains, in many areas, an active area of debate. But the direction of science is clear: the immune system is<\/em> central to pregnancy and it does<\/em> go wrong in some women who miscarry\u2014perhaps especially in women with repeat miscarriage. Furthermore, those women deserve better than being handed a statistic and a pamphlet about grief.<\/p>\n\n\n\n Dr. Beer spent decades fighting for that belief. Researchers in labs across the world are building on his foundation. And the women who have lost pregnancies and who have sat in waiting rooms and not received helpful answers, deserve to know that the question is still being asked on their behalf. Because “unexplained” is not the same as “unexplainable.” At least not anymore when it comes to miscarriages.<\/p>\n\n\n\n If you have experienced two or more miscarriages and you are struggling to understand why, speak with a reproductive specialist or maternal-fetal medicine physician about immune testing, particularly antiphospholipid antibody screening. You can also ask your healthcare professional about referral to a reproductive immunologist. The ESHRE guidelines<\/a> on recurrent pregnancy loss (updated 2022) are a useful reference for understanding what investigations are currently recommended [14]. Take a look and embrace the next stage of your fertility journey with confidence and hope.<\/p>\n\n\n\nThe immunological miracle nobody talks about<\/span><\/h2>\n\n\n\n
The man who changed everything: Dr. Alan Beer<\/span><\/h2>\n\n\n\n
What is actually happening in the body<\/span><\/h2>\n\n\n\n
Natural Killer Cells (NK Cells)<\/span><\/h3>\n\n\n\n
Regulatory T Cells (Tregs)<\/span><\/h3>\n\n\n\n
Antiphospholipid Syndrome (APS)<\/span><\/h3>\n\n\n\n
What no one is telling women who miscarry<\/span><\/h2>\n\n\n\n
What testing might be available?<\/span><\/h2>\n\n\n\n
What treatments exist?<\/span><\/h2>\n\n\n\n
\n
A field still developing<\/span><\/h2>\n\n\n\n
References<\/span><\/h4>\n\n\n\n